Paper21085486
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
Vaine M and 7 others. PLoS One, 2010. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies. Papers, record 21085486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21085486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| HIV Antibodies | Major topic |
| HIV Envelope Protein gp120 | Major topic |
| HIV Infections | Major topic |
| Antibodies, Neutralizing | |
| Antibody Specificity | |
| Antibody-Dependent Cell Cytotoxicity | |
| Enzyme-Linked Immunosorbent Assay | |
| HIV-1 | |
| Humans |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI082274 | NIAID NIH HHS | United States | P01AI082274 | PubMed and NIH | NIH RePORTER |
| AI082676 | NIAID NIH HHS | United States | U19AI082676 | PubMed and NIH | NIH RePORTER |
| AI065250 | NIAID NIH HHS | United States | R01AI065250 | PubMed and NIH | NIH RePORTER |
| U19 AI082676 | NIAID NIH HHS | United States | U19AI082676 | PubMed and NIH | NIH RePORTER |
| R01 AI065250 | NIAID NIH HHS | United States | R01AI065250 | PubMed and NIH | NIH RePORTER |
| P01 AI082274 | NIAID NIH HHS | United States | P01AI082274 | PubMed and NIH | NIH RePORTER |
| U01 AI068618 | NIAID NIH HHS | United States | U01AI068618 | PubMed and NIH | NIH RePORTER |
| AI 27742 | NIAID NIH HHS | United States | P30AI027742 | PubMed and NIH | NIH RePORTER |
| P30 AI027742 | NIAID NIH HHS | United States | P30AI027742 | PubMed and NIH | NIH RePORTER |
| R21 AI087191 | NIAID NIH HHS | United States | R21AI087191 | PubMed and NIH | NIH RePORTER |
| ZIAAI000883 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00027365 | An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV | Results |
Source ClinicalTrials.gov
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12190851 | Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge. | J Med Primatol | 2002 | https://conductscience.org/library/papers/12190851 | PubMed |
| 2 | 17721546 | Broad HIV-1 neutralization mediated by CD4-binding site antibodies. | Nat Med | 2007 | https://conductscience.org/library/papers/17721546 | PubMed |
| 3 | 19287373 | Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. | Nature | 2009 | https://conductscience.org/library/papers/19287373 | PubMed |
| 4 | 16989638 | Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. | Expert Rev Vaccines | 2006 | https://conductscience.org/library/papers/16989638 | PubMed |
| 5 | 12743303 | Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding. | J Virol | 2003 | https://conductscience.org/library/papers/12743303 | PubMed |
| 6 | 19004942 | Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals. | J Virol | 2009 | https://conductscience.org/library/papers/19004942 | PubMed |
| 7 | 19012954 | Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. | Lancet | 2008 | https://conductscience.org/library/papers/19012954 | PubMed |
| 8 | 15752839 | Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. | Vaccine | 2005 | https://conductscience.org/library/papers/15752839 | PubMed |
| 9 | 16306625 | Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. | J Virol | 2005 | https://conductscience.org/library/papers/16306625 | PubMed |
| 10 | 16912322 | Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection. | J Virol | 2006 | https://conductscience.org/library/papers/16912322 | PubMed |
| 11 | 10196297 | Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. | J Virol | 1999 | https://conductscience.org/library/papers/10196297 | PubMed |
| 12 | 9593008 | Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. | J Infect Dis | 1998 | https://conductscience.org/library/papers/9593008 | PubMed |
| 13 | 17038830 | Role of neutralizing antibodies in protective immunity against HIV. | Hum Vaccin | 2005 | https://conductscience.org/library/papers/17038830 | PubMed |
| 14 | 18833271 | Challenges in the development of an HIV-1 vaccine. | Nature | 2008 | https://conductscience.org/library/papers/18833271 | PubMed |
| 15 | 16343526 | A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. | J Immunol Methods | 2006 | https://conductscience.org/library/papers/16343526 | PubMed |
| 16 | 8794312 | The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. | J Virol | 1996 | https://conductscience.org/library/papers/8794312 | PubMed |
| 17 | 19729618 | Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. | Science | 2009 | https://conductscience.org/library/papers/19729618 | PubMed |
| 18 | 18833294 | B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4. | PLoS Pathog | 2008 | https://conductscience.org/library/papers/18833294 | PubMed |
| 19 | 15867093 | Antigenic conservation and immunogenicity of the HIV coreceptor binding site. | J Exp Med | 2005 | https://conductscience.org/library/papers/15867093 | PubMed |
| 20 | 11462019 | Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. | J Virol | 2001 | https://conductscience.org/library/papers/11462019 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38773089 | Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. | Nat Commun | 2024 | https://conductscience.org/library/papers/38773089 | PubMed |
| 36009408 | Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections. | Biomedicines | 2022 | https://conductscience.org/library/papers/36009408 | PubMed |
| 35140230 | Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/35140230 | PubMed |
| 32747654 | Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature. | Sci Rep | 2020 | https://conductscience.org/library/papers/32747654 | PubMed |
| 30615119 | Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period. | J Infect Dis | 2019 | https://conductscience.org/library/papers/30615119 | PubMed |
| 28933684 | Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines. | Hum Vaccin Immunother | 2017 | https://conductscience.org/library/papers/28933684 | PubMed |
| 28701402 | Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site. | J Virol | 2017 | https://conductscience.org/library/papers/28701402 | PubMed |
| 28615206 | Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer. | J Virol | 2017 | https://conductscience.org/library/papers/28615206 | PubMed |
| 27455880 | Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques. | Mol Ther | 2016 | https://conductscience.org/library/papers/27455880 | PubMed |
| 27048742 | DNA immunization as a technology platform for monoclonal antibody induction. | Emerg Microbes Infect | 2016 | https://conductscience.org/library/papers/27048742 | PubMed |
| 26656117 | Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination. | Clin Vaccine Immunol | 2016 | https://conductscience.org/library/papers/26656117 | PubMed |
| 26590319 | A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines. | J Immunol | 2016 | https://conductscience.org/library/papers/26590319 | PubMed |
| 26491157 | Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity. | J Virol | 2016 | https://conductscience.org/library/papers/26491157 | PubMed |
| 26344472 | DNA Immunization for HIV Vaccine Development. | Vaccines (Basel) | 2014 | https://conductscience.org/library/papers/26344472 | PubMed |
| 26344467 | Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine. | Vaccines (Basel) | 2013 | https://conductscience.org/library/papers/26344467 | PubMed |
| 26109728 | Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL. | J Virol | 2015 | https://conductscience.org/library/papers/26109728 | PubMed |
| 25245278 | HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile. | AIDS Res Hum Retroviruses | 2014 | https://conductscience.org/library/papers/25245278 | PubMed |
| 25202303 | The influence of delivery vectors on HIV vaccine efficacy. | Front Microbiol | 2014 | https://conductscience.org/library/papers/25202303 | PubMed |
| 25013066 | A critical question for HIV vaccine development: which antibodies to induce? | Science | 2014 | https://conductscience.org/library/papers/25013066 | PubMed |
| 24794644 | Mucosal vaccines against respiratory syncytial virus. | Curr Opin Virol | 2014 | https://conductscience.org/library/papers/24794644 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
| NDUFB3 | 4709 | PubTator's text mining | https://conductscience.org/library/genes/4709 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21085486
GET https://conductscience.org/api/papers/v1/21085486/references?page=2